课题基金 / 基金详情

SPECIFIC IMMUNITY DEVELOPMENT IN HUMAN NEWBORNS

SPECIFIC IMMUNITY DEVELOPMENT IN HUMAN NEWBORNS
人类新生儿的特异性免疫发育
批准号:
6114924
负责人:
Anthony R. Hayward
金额:
$1.99万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

Anthony R. Hayward的其他基金

相似基金

相关文献

中文摘要
翻译
本研究着眼于早产儿和足月对照组接种乙肝疫苗的结果,验证了T细胞对葡萄球菌内毒素B的激活反应将预测9个月后抗体滴度的假设。脐带血是在出生时从早产儿中获得的,在过去一年中又收集了四个样本。允许测试反应,并在随访中测量对乙肝的抗体反应。目前被跟踪的受试者总数为36人,目前该研究将对新进入者关闭。
英文摘要
This study looks at the outcome of Hepatitis B vaccination in prematures and term controls, testing the hypothesis that the T cell activation response to staph endotoxin B will predict the titer of antibody after 9 months. Cord blood is obtained at birth from prematures and a further four samples have been accrued in the past year. Permission to test the response, and to measure the antibody response to Hepatitis B is obtained at follow up. The total number of subjects being followed is currently 36, and the study will be closed to new entrants at this point.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRAINING PROGRAM IN PEDIATRIC IMMUMOLOGY
  • 批准号:
    6149809
  • 项目类别:
  • 资助金额:
    $14.95万
  • 财政年份:
    2000
  • 负责人:
    Anthony R. Hayward
  • 依托单位:
CELLULAR IMMUNITY TO CRYPTOSPORIDIUM PARVUM
  • 批准号:
    2887373
  • 项目类别:
  • 资助金额:
    $14.29万
  • 财政年份:
    1998
  • 负责人:
    Anthony R. Hayward
  • 依托单位:
CELLULAR IMMUNITY TO CRYPTOSPORIDIUM PARVUM
  • 批准号:
    2712314
  • 项目类别:
  • 资助金额:
    $13.88万
  • 财政年份:
    1998
  • 负责人:
    Anthony R. Hayward
  • 依托单位:
CELLULAR IMMUNITY TO CRYPTOSPORIDIUM PARVUM
  • 批准号:
    6169792
  • 项目类别:
  • 资助金额:
    $14.72万
  • 财政年份:
    1998
  • 负责人:
    Anthony R. Hayward
  • 依托单位:
海外基金